2022 annual financial data
Summit Therapeutics 2022 Financial results
Direct answer
Revenue was 583,190 GBP.
Operating income was -59,633,462 GBP and net income was -65,170,046 GBP.
Operating cash flow was -33,897,438 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 583,190 GBP
- Operating income
- -59,633,462 GBP
- Net income
- -65,170,046 GBP
- Operating cash flow
- -33,897,438 GBP
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Summit Therapeutics financial years